Publication Name	World Journal of Gastroenterology
Manuscript ID	10052
Country	China

Received	2014-03-11 10:04
Peer-Review Started	2014-03-11 14:29
First Decision by Editorial Office Director
Return for Revision	2014-04-12 07:50
Revised	2014-04-19 10:55
Publication Fee Transferred
Second Decision by Editor	2014-07-22 16:57
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-07-22 18:21
Articles in Press	2014-07-22 18:34
Edit the Manuscript by Language Editor	2014-07-30 21:32
Typeset the Manuscript	2014-11-21 14:57
Publish the Manuscript Online	2014-12-10 15:52

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Meta-Analysis
Article Title	Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: A meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Jia-Yan Ni, Lin-Feng Xu, Wei-Dong Wang, Hong-Liang Sun and Yao-Ting Chen
Funding Agency and Grant Number
Corresponding Author	Lin-Feng Xu, MD, PhD, Department of Interventional Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107 Yanjiang Road West, Guangzhou 510210, Guangdong Province, China. xu_lin_feng@163.com
Key Words	Hepatocellular carcinoma; Transarterial chemoembolizaiton; Yttrium-90 microsphere; Drug-eluting bead; Meta-analysis
Core Tip	Microsphere embolization has been performed more and more widely for the treatment of hepatocellular carcinoma (HCC). Whether microsphere embolization or conventional transarterial chemoembolization (c-TACE) is the better choice has been debated. In this study, we performed a meta-analysis to comprehensively compare the efficacy and safety of microspheres embolization with those of c-TACE in HCC. Our analysis indicated that microsphere embolization was associated with superior survival and treatment response in comparison with c-TACE in patients with HCC. We hope that the comparison of these treatments could help stratify the benefits of treatment choices for patients with HCC.
Publish Date	2014-12-10 15:52
Citation	Ni JY, Xu LF, Wang WD, Sun HL, Chen YT. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2014; 20(45): 17206-17217
URL	http://www.wjgnet.com/1007-9327/full/v20/i45/17206.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i45.17206

Full Article (PDF)	WJG-20-17206.pdf
Full Article (Word)	WJG-20-17206.doc
Manuscript File	10052-Review.doc
Answering Reviewers	10052-Answering reviewers.pdf
Copyright License Agreement	10052-Copyright assignment.pdf
Peer-review Report	10052-Peer review.pdf
Scientific Misconduct Check	10052-Crosscheck.JPG
Scientific Editor Work List	10052-Scientific editor work list.pdf